Sources | Names Used |
---|---|
CTRPv2 | BRD-K03911514 |
PharmacoGx | BRD-K03911514 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DYNLRB1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
mRNA | ACBD6 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
mRNA | ADAM20 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
mRNA | NDN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
mRNA | GINS2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
mRNA | EFCAB6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
mRNA | THYN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
mRNA | ADAMTS16 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
mRNA | ACTR3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |